Journal
CELL
Volume 146, Issue 5, Pages 772-784Publisher
CELL PRESS
DOI: 10.1016/j.cell.2011.07.033
Keywords
-
Categories
Funding
- NIH
- Melanoma Research Alliance
- Janey Fund and Seraph Foundation
- Stewart Trust
Ask authors/readers for more resources
T cell differentiation into distinct functional effector and inhibitory subsets is regulated, in part, by the cytokine environment present at the time of antigen recognition. Here, we show that hypoxia-inducible factor 1 (HIF-1), a key metabolic sensor, regulates the balance between regulatory T cell (T-reg) and T(H)17 differentiation. HIF-1 enhances T(H)17 development through direct transcriptional activation of ROR gamma t and via tertiary complex formation with ROR gamma t and p300 recruitment to the IL-17 promoter, thereby regulating T(H)17 signature genes. Concurrently, HIF-1 attenuates T-reg development by binding Foxp3 and targeting it for proteasomal degradation. Importantly, this regulation occurs under both normoxic and hypoxic conditions. Mice with HIF-1 alpha-deficient T cells are resistant to induction of T(H)17-dependent experimental autoimmune encephalitis associated with diminished T(H)17 and increased T-reg cells. These findings highlight the importance of metabolic cues in T cell fate determination and suggest that metabolic modulation could ameliorate certain T cell-based immune pathologies.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available